We are live on ! Find out more
EI

EAM Investors Portfolio holdings

AUM $866M
1-Year Est. Return 377.14%
This Fund
S&P 500
This Quarter Est. Return
+31.48%
1 Year Est. Return
+377.14%
3 Year Est. Return
+5,228.32%
5 Year Est. Return
+49,813.17%
10 Year Est. Return
+19,957,666.26%
AUM
$717M
AUM Growth
+$224M
Cap. Flow
+$115M
Cap. Flow %
16.05%
Top 10 Hldgs %
8.55%
Holding
426
New
116
Increased
108
Reduced
81
Closed
120

Sector Composition

Rank Sector Weight
1 Healthcare 26.56%
2 Technology 18.16%
3 Consumer Discretionary 12.48%
4 Industrials 11.12%
5 Financials 5.65%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SLI
426
DELISTED
S L INDUSTRIES INC (DELAWARE)
SLI
-39,837
Closed -$1.95M

Similar funds

EAM Investors's Q4 2014 Portfolio in Review

As of Q4 2014, EAM Investors held 426 positions worth $717M, up 46% from $492M the previous quarter. Its ten largest holdings account for 8.6% of the portfolio.

EAM Investors deployed $115M of net new capital in Q4 2014, opening 116 new positions and adding to 108 existing holdings. Its largest new stake was Callidus Software, Inc.: 247,614 shares worth $4.04M.

By sector, the portfolio is most concentrated in Healthcare at 27% of assets, up from 20% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was STRATTEC Security, an estimated $1.37M trimmed.

  • EAM Investors's largest Q4 2014 buy was Callidus Software, Inc.: 247,614 shares worth $4.04M.
  • EAM Investors added most to Esperion Therapeutics in Q4 2014, an estimated $3.52M increase.
  • EAM Investors's biggest Q4 2014 reduction was STRATTEC Security, cutting an estimated $1.37M.
  • EAM Investors fully exited Pixelworks in Q4 2014, selling an estimated $3.85M.
  • EAM Investors's ten largest holdings make up 8.6% of its $717M portfolio in Q4 2014.
  • EAM Investors opened 116 new positions and closed 120 in Q4 2014.
  • EAM Investors's portfolio value rose 46% quarter-over-quarter to $717M.

Based on EAM Investors's 13F filing for Q4 2014, filed 9 Feb 2015.